People
Aglaris Ltd. today announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish cell therapy equipment manufacturer, effective immediately.
Probiodrug AG announced today that effective October 31, 2018, and with the contractual termination of her current agreement, Dr. Inge Lues’ term as Chief Development Officer will come to an end.
Bristol-Myers Squibb, Nektar Therapeutics, Amgen and others will be recognized for their significant contributions to the California life sciences industry during the November 2018 Pantheon DiNA Awards hosted by the California Life Sciences Association.
In a report, Bloomberg said that pharma’s “efforts to maximize (financial) gains” has led to the coloring of R&D decisions and creating barriers to the entry of competing medications that can add costs to the health care system.
Transition continues as biotech companies continue to adjust their leadership ranks and strengthen the members of their organization representing and overseeing the companies. Here is a look at some of those transitions.
A former employee in Biogen’s IT department, filed a lawsuit in federal court last month claiming the company discriminated against him because of his Parkinson’s disease.
After negative reports about after-hours parties that have been deemed disrespectful toward women, and multiple reports about the lack of gender diversity on industry boards of directors, biotech’s biggest trade association is taking action.
IUPUI biologist Nick Berbari has received a $1.75 million grant from the National Institutes of Health to study the connection between obesity and tiny hairlike projections on brain cells called cilia.
Aaron E. Carroll, M.D., a nationally recognized research scientist, research team leader and a New York Times writer and book author, has been selected as Regenstrief Institute’s first-ever vice president for faculty development.
Sexual harassment has been a big focus in the news as of late, but much of this focus has been primarily concerned with the harassment issues in Hollywood and the political sphere. However, the scientific community has long been criticized for being a hostile environment for women as well.
PRESS RELEASES